1. The synergistic effect of phototherapy and active substances on hair growth.
- Author
-
Qiu S, Pan Z, Jiang X, Lv G, Feng A, and Chen H
- Subjects
- Humans, Vascular Endothelial Growth Factor A metabolism, Arginine chemistry, Arginine pharmacology, Alopecia therapy, Hair Follicle radiation effects, Hair Follicle metabolism, Hair Follicle drug effects, Low-Level Light Therapy, Intercellular Signaling Peptides and Proteins metabolism, Oligopeptides chemistry, Oligopeptides pharmacology, Male, Collagen metabolism, Collagen chemistry, Wnt Signaling Pathway drug effects, Wnt Signaling Pathway radiation effects, Cell Line, Mitochondria metabolism, Mitochondria drug effects, Mitochondria radiation effects, Cell Proliferation drug effects, Cell Proliferation radiation effects, Fibroblasts metabolism, Fibroblasts cytology, Fibroblasts radiation effects, Fibroblasts drug effects, beta Catenin metabolism, Hair radiation effects, Hair growth & development, Hair drug effects
- Abstract
Androgenic alopecia (AGA) typically manifests post-puberty, resulting in decreases in hair density, disruptions in the hair growth cycle, and alterations in hair follicle micro structure. Dihydrotestosterone (DHT) is a key hormone implicated in hair loss, especially on male. In this study, we found that each of arginine (Arg), arterial extract (AE) or biotin tripeptide-1 (BT-1), when combined with low level light therapy (LLLT, at 630 nm, 2 J/cm
2 ), showed the efficacy in enhancing mitochondrial functions, cell proliferation and collagen synthesis in fibroblasts. Additionally, CARRIPOWER (the complexes of AE, BT-1, Arg, and Diaminopyrimidine derivatives), in conjunction with LLLT (630 nm, 2 J/cm2 ), showed promising results in dermal papilla cells (DPCs). The promising results contained not also inflammatory cytokines (IL-1β and IL-6) and cell pro apoptotic factor (TGF-β2) reduction, but also Wnt pathway inhibition by decreasing DKK1 level, and pro-hair growth factors (vascular endothelial growth factor (VEGF) and β-catenin) increase. This innovative combination therapy offers a potential solution for the treatment of AGA, addressing both hormonal and cellular factors involved in hair loss., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF